GlassScriptPhysician profile
Logan West
NPI 1467153080
$2,075.90
in general payments reported to CMS, 2019-2025
19 companies · $816 in 2025
The $816 reported for 2025 was more than what 94% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $895 · 2024: $365 · 2025: $816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,484 · Travel and Lodging: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,484.06 |
| Travel and Lodging | $591.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $894.56 | 2023 | Axonics |
| Astellas Pharma US INC | $285.26 | 2024-2025 | Veozah |
| Sage Therapeutics, LLC | $153.92 | 2024-2025 | Zurzuvae |
| Amgen INC. | $70.86 | 2024-2025 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $70.31 | 2025 | |
| Organon LLC | $64.28 | 2024-2025 | Nexplanon |
| Pfizer INC. | $64.00 | 2024-2025 | |
| Exact Sciences Corporation | $57.10 | 2024-2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $56.45 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.86 | 2024-2025 | |
| Exeltis, USA INC. | $52.05 | 2025 | Slynd |
| Hologic Sales and Service, LLC | $48.02 | 2025 | Aptima |
| Millicent US INC | $47.23 | 2024-2025 | Femring, Intrarosa |
| Merck Sharp & Dohme LLC | $38.64 | 2024 | Gardasil, Gardasil 9 |
| Coopersurgical, INC. | $35.04 | 2024-2025 | Paragard T 380a |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $25.38 | 2025 | |
| Evofem Biosciences, INC. | $22.32 | 2025 | Solosec, Phexx, Phexxi |
| Aspira Women'S Health INC | $18.90 | 2025 | Ova1 |
| Sumitomo Pharma America, INC. | $15.72 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.